Related Experiment Video

Updated: Aug 11, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
08:32

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production

Published on: March 2, 2014

Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity

Avner Friedman1, Jianjun Paul Tian, Giulia Fulci

  • 1Mathematical Biosciences Institute, The Ohio State University, Columbus 43210, USA.

Cancer Research
|February 21, 2006
PubMed

Insights

Oncolytic virus therapy for brain cancer shows promise. Enhancing virus burst size and using cyclophosphamide may significantly reduce tumor size and spread.

Area of Science:

  • Oncology
  • Virology
  • Immunology
  • Mathematical Biology

Background:

  • Oncolytic viruses selectively infect and lyse cancer cells, sparing normal cells.
  • Herpes simplex virus 1 (hrR3) has shown limited efficacy against glioma in rats due to immune system interference.
  • Cyclophosphamide, an immunosuppressive agent, can reduce immune cell presence in tumors.

Purpose of the Study:

  • To investigate the impact of cyclophosphamide treatment protocols and increased viral burst size on glioma growth.
  • To develop a mathematical model for predicting the efficacy of oncolytic virotherapy in brain tumors.

Main Methods:

  • Mathematical modeling was employed to simulate tumor growth dynamics.
  • The model incorporated parameters for cyclophosphamide treatment and viral burst size.
  • Simulations were performed to assess the effects of varying treatment strategies.

Main Results:

  • A threefold increase in viral burst size could potentially reduce tumor diameter from 4 mm to 1 mm.
  • Repeated cyclophosphamide treatment helps maintain a low density of uninfected tumor cells.
  • This reduction in uninfected cells lowers the probability of tumor cell migration.

Conclusions:

  • Optimizing oncolytic virus burst size is crucial for enhancing therapeutic efficacy.
  • Strategic immunosuppression with cyclophosphamide can improve oncolytic virotherapy outcomes by controlling tumor cell spread.
  • Mathematical modeling provides a valuable tool for predicting and optimizing cancer treatment strategies.

More Related Videos

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma10:02

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma

Published on: June 2, 2023

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...